Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SMRA.JK Stock Summary
In the News
SMRA.JK Financial details
Company Rating
Buy
Market Cap
8584.47B
Income
765.97B
Revenue
6658.78B
Book val./share
595.26
Cash/share
199.46
Dividend
7
Dividend %
1.14%
Employees
2.54K
Optionable
No
Shortable
Yes
Earnings
17 May 2024
P/E
10.48
Forward P/E
-
PEG
4.66
P/S
1.54
P/B
1.04
P/C
2.51
P/FCF
20.14
Quick Ratio
0.27
Current Ratio
1.25
Debt / Equity
0.73
LT Debt / Equity
0.28
-
-
EPS (TTM)
46.39
EPS next Y
-
EPS next Q
-
EPS this Y
22.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.05%
Revenue last 5Y
2.31%
Revenue Q/Q
-25.44%
EPS Q/Q
-48.46%
-
-
-
-
SMA20
-5.68%
SMA50
-11.66%
SMA100
-9.81%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
10%
ROC
0.11%
Gross Margin
52%
Oper. Margin
30%
Profit Margin
15%
Payout
12%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
505.0-740.0
52W High
-32.43%
52W Low
-0.99%
RSI
38
Rel Volume
1.31
Avg Volume
42.89M
Volume
56.32M
Perf Week
-4.76%
Perf Month
-11.5%
Perf Quarter
-
Perf Half Y
-11.5%
-
-
-
-
Beta
1.24
-
-
Volatility
10.25%, 17.96%
Prev Close
0%
Price
500
Change
-0.99%
SMRA.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 399.07 | 337.84 | 358.19 | 346.45 | 403.35 | |
Net income per share | 34.59 | 16.52 | 35.36 | 37.88 | 46.4 | |
Operating cash flow per share | 33.9 | -1.54 | 157.29 | 37.88 | 84.76 | |
Free cash flow per share | 18.56 | -18.8 | 155.03 | 35.24 | 13.83 | |
Cash per share | 112.14 | 111.27 | -171.58 | -160.22 | 199.46 | |
Book value per share | 494.85 | 459.8 | 557.18 | 557.13 | 595.26 | |
Tangible book value per share | 634.8 | 610.24 | 722.45 | 711.75 | 745.25 | |
Share holders equity per share | 494.85 | 459.8 | 557.18 | 557.13 | 595.26 | |
Interest debt per share | 653.87 | 703.47 | 516.57 | 407.51 | 487.9 | |
Market cap | 14963.24B | 11613.55B | 12979.8B | 9987.68B | 9657.51B | |
Enterprise value | 22267.82B | 19415.15B | 17250.89B | 12759.65B | 13567.98B | |
P/E ratio | 29.06 | 47.23 | 23.61 | 15.97 | 12.61 | |
Price to sales ratio | 2.52 | 2.31 | 2.33 | 1.75 | 1.45 | |
POCF ratio | 29.65 | -506.44 | 5.31 | 15.97 | 6.9 | |
PFCF ratio | 54.16 | -41.49 | 5.39 | 17.17 | 42.3 | |
P/B Ratio | 2.03 | 1.7 | 1.5 | 1.09 | 0.98 | |
PTB ratio | 2.03 | 1.7 | 1.5 | 1.09 | 0.98 | |
EV to sales | 3.75 | 3.86 | 3.1 | 2.23 | 2.04 | |
Enterprise value over EBITDA | 14.84 | 14.65 | 10.86 | 7.75 | 7.23 | |
EV to operating cash flow | 44.12 | -846.65 | 7.06 | 20.4 | 9.7 | |
EV to free cash flow | 80.59 | -69.36 | 7.16 | 21.93 | 59.43 | |
Earnings yield | 0.03 | 0.02 | 0.04 | 0.06 | 0.08 | |
Free cash flow yield | 0.02 | -0.02 | 0.19 | 0.06 | 0.02 | |
Debt to equity | 1.22 | 1.38 | 0.81 | 0.64 | 0.73 | |
Debt to assets | 0.37 | 0.38 | 0.27 | 0.21 | 0.23 | |
Net debt to EBITDA | 4.87 | 5.89 | 2.69 | 1.68 | 2.08 | |
Current ratio | 1.24 | 1.42 | 1.87 | 1.5 | 1.32 | |
Interest coverage | 2.07 | 1.26 | 1.58 | 2.1 | 1.88 | |
Income quality | 0.98 | -0.13 | 7.55 | 1 | 1.83 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.14 | 0 | 0 | 0.16 | 0.15 | |
Sales general and administrative to revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.52 | 0.5 | -0.21 | -0.21 | 0 | |
Capex to operating cash flow | -0.45 | 11.21 | -0.01 | -0.07 | -0.84 | |
Capex to revenue | -0.04 | -0.05 | -0.01 | -0.01 | -0.18 | |
Capex to depreciation | -0.82 | -0.93 | -0.13 | -0.17 | -4.44 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 620.57 | 413.36 | 665.82 | 689.11 | 788.3 | |
ROIC | 0.09 | 0.08 | 0.1 | 0.11 | 0.09 | |
Return on tangible assets | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham Net | -594.08 | -625.56 | -810.67 | -852.08 | -597.38 | |
Working capital | 2133.41B | 3529.76B | 6061.77B | 4789.35B | 3776.51B | |
Tangible asset value | 3298.44B | 3459.59B | 16744.43B | 17668.39B | 12303.06B | |
Net current asset value | 3839.55B | 3947.93B | 1788.96B | 2392.91B | 3303.08B | |
Invested capital | 1.22 | 1.38 | 0.81 | 0.64 | 0.73 | |
Average receivables | 342.53B | 327.52B | 354.01B | 360.17B | 350.22B | |
Average payables | 81.44B | 83.41B | 75.77B | 79.14B | 89.42B | |
Average inventory | 8202.29B | 8850.66B | 9220.45B | 9606.76B | 10447.08B | |
Days sales outstanding | 17.89 | 26.4 | 22.56 | 24.01 | 17.78 | |
Days payables outstanding | 10.02 | 10.76 | 8.7 | 11.73 | 9.92 | |
Days of inventory on hand | 990.49 | 1.22K | 1.14K | 1.34K | 1.19K | |
Receivables turnover | 20.4 | 13.82 | 16.18 | 15.2 | 20.53 | |
Payables turnover | 36.43 | 33.94 | 41.97 | 31.11 | 36.78 | |
Inventory turnover | 0.37 | 0.3 | 0.32 | 0.27 | 0.31 | |
ROE | 0.07 | 0.04 | 0.06 | 0.07 | 0.08 | |
Capex per share | -15.34 | -17.26 | -2.26 | -2.64 | -70.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 91.32 | 90.82 | 88.75 | 128.2 | 95.58 | |
Net income per share | 19.12 | 16.46 | 9.82 | 13.27 | 6.84 | |
Operating cash flow per share | 19.12 | 16.46 | 19.75 | 19.46 | 16.84 | |
Free cash flow per share | 17.94 | 15.47 | 18.72 | 17.61 | -4.1 | |
Cash per share | -160.22 | -146.26 | -159.43 | -173.66 | 199.46 | |
Book value per share | 557.13 | 573.76 | 576.8 | 590.23 | 595.26 | |
Tangible book value per share | 711.75 | 729.12 | 727.1 | 749.46 | 745.25 | |
Share holders equity per share | 557.13 | 573.76 | 576.8 | 590.23 | 595.26 | |
Interest debt per share | 361.69 | 371.14 | 387.2 | 403.94 | 451.03 | |
Market cap | 9987.68B | 8749.54B | 10895.66B | 9492.43B | 9657.51B | |
Enterprise value | 12759.65B | 11442B | 13909.88B | 12811.21B | 13567.98B | |
P/E ratio | 7.91 | 8.05 | 16.8 | 10.83 | 21.38 | |
Price to sales ratio | 6.62 | 5.84 | 7.44 | 4.49 | 6.12 | |
POCF ratio | 31.64 | 32.2 | 33.42 | 29.55 | 34.74 | |
PFCF ratio | 33.73 | 34.26 | 35.26 | 32.66 | -142.59 | |
P/B Ratio | 1.09 | 0.92 | 1.14 | 0.97 | 0.98 | |
PTB ratio | 1.09 | 0.92 | 1.14 | 0.97 | 0.98 | |
EV to sales | 8.46 | 7.63 | 9.49 | 6.05 | 8.6 | |
Enterprise value over EBITDA | 29.95 | 24.62 | 32.78 | 20.96 | 38.67 | |
EV to operating cash flow | 40.42 | 42.11 | 42.67 | 39.88 | 48.81 | |
EV to free cash flow | 43.09 | 44.8 | 45.01 | 44.07 | -200.32 | |
Earnings yield | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.03 | 0.03 | 0.03 | 0.03 | -0.01 | |
Debt to equity | 0.64 | 0.63 | 0.65 | 0.67 | 0.73 | |
Debt to assets | 0.21 | 0.21 | 0.21 | 0.22 | 0.23 | |
Net debt to EBITDA | 6.51 | 5.79 | 7.1 | 5.43 | 11.15 | |
Current ratio | 1.5 | 1.53 | 1.28 | 1.25 | 1.32 | |
Interest coverage | 7.57 | 2.83 | 2.67 | 3.52 | 1.13 | |
Income quality | 1 | 1 | 2.01 | 1.47 | 2.46 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 0 | 0.52 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.04 | 0.04 | 0.02 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | -0.21 | -0.2 | -0.2 | -0.21 | 0 | |
Capex to operating cash flow | -0.06 | -0.06 | -0.05 | -0.1 | -1.24 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.22 | |
Capex to depreciation | -0.26 | -0.25 | -0.26 | -0.48 | -4.9 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 489.61 | 460.96 | 357.05 | 419.86 | 302.71 | |
ROIC | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Graham Net | -852.08 | -842.51 | -890.9 | -893.48 | -597.38 | |
Working capital | 4789.35B | 5045.07B | 3244.41B | 2933.2B | 3776.51B | |
Tangible asset value | 17668.39B | 17828.2B | 17959.8B | 18522.75B | 12303.06B | |
Net current asset value | 2392.91B | 2265.92B | 2701.89B | 2650.16B | 3303.08B | |
Invested capital | 0.64 | 0.63 | 0.65 | 0.67 | 0.73 | |
Average receivables | 359.6B | 364.39B | 344.56B | 329.49B | 323.37B | |
Average payables | 74.3B | 83.09B | 70.74B | 68.22B | 82.57B | |
Average inventory | 9941.53B | 10004.54B | 10179.75B | 10157.27B | 10469.53B | |
Days sales outstanding | 22.46 | 21.17 | 20.67 | 13.71 | 18.5 | |
Days payables outstanding | 11.82 | 9.77 | 8.09 | 6.03 | 10.19 | |
Days of inventory on hand | 1.35K | 1.25K | 1.33K | 817.83 | 1.22K | |
Receivables turnover | 4.01 | 4.25 | 4.35 | 6.56 | 4.87 | |
Payables turnover | 7.62 | 9.22 | 11.13 | 14.93 | 8.83 | |
Inventory turnover | 0.07 | 0.07 | 0.07 | 0.11 | 0.07 | |
ROE | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | |
Capex per share | -1.19 | -0.99 | -1.03 | -1.85 | -20.94 |
SMRA.JK Frequently Asked Questions
What is PT Summarecon Agung Tbk stock symbol ?
PT Summarecon Agung Tbk is a ID stock and trading under the symbol SMRA.JK
What is PT Summarecon Agung Tbk stock quote today ?
PT Summarecon Agung Tbk stock price is $500 today.
Is PT Summarecon Agung Tbk stock public?
Yes, PT Summarecon Agung Tbk is a publicly traded company.